Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Verapamil prophylaxis for 5-fluorouracil-associated cardiac symptoms in gastrointestinal cancer
IRCT20251216068357N1Phase 2Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of verapamil in gastrointestinal cancer (2 arms), sponsored by Kashan University of Medical Sciences. Primary endpoints: ECG changes and Echocardiography changes. Started Jan 2026; status: completed.
02
Drugs
verapamil
03
Conditions
gastrointestinal cancer
Beyond the preview
Go deeper on IRCT20251216068357N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251216068357N1.